Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d241434dd2e686fcc5aab7061164f8c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21007 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 |
filingDate |
2000-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eedda026de03f43080e5f6fd9fe5815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60209871e4e841087fefafc93bfc069b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab94d75d32f8ecffb5493214aa917995 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b0e7f26942cfde951ea1446480cf534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fed5e2f80ede08239b72134df7cd6358 |
publicationDate |
2007-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7157556-B1 |
titleOfInvention |
Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use |
abstract |
Disclosed are deglycosylated fragments of a kringle 1-3 region of plasminogen, nucleotides encoding deglycosylated kringle 1-3 region proteins and antibodies specific for deglycosylated kringle 1-3 region proteins. The compositions of the present invention have increased antiangiogenic activity as compared to previously isolated kringle 1-3 region proteins. Also included in the present invention are methods of treating angiogenesis-associated diseases and conditions such as cancer using the compositions described herein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010184661-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008083615-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2597105-A1 |
priorityDate |
1999-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |